Assessment of inotropic and vasodilating effects of milrinone lactate in patients with dilated cardiomyopathy and severe heart failure

Arquivos Brasileiros de Cardiologia

Volumn 72, Issue 2, 1999, Pages 155-160

  Bregagnollo, Edson Antonio ^a   Fortes, Adjair Humberto ^b   Cicogna, Antonio Carlos ^b  

^a SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

^b NONE

Author keywords

Heart failure; Inotropic agents; Milrinone

Indexed keywords

MILRINONE;

ARTICLE; CLINICAL ARTICLE; DRUG EFFECT; HEART DILATATION; HEART FAILURE; HEART FUNCTION; HEART OUTPUT; HUMAN; INOTROPISM; INTRAVENOUS DRUG ADMINISTRATION; VASODILATATION;

ADULT; CARDIOMYOPATHY, DILATED; CARDIOTONIC AGENTS; FEMALE; HEART FAILURE, CONGESTIVE; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; MILRINONE; SEVERITY OF ILLNESS INDEX; VASODILATOR AGENTS;

EID: 0032777454     PISSN: 0066782X     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0066-782x1999000200003     Document Type: Article

References (35)

1. Leiel CV, Heban PT, Huss P - Comparative systemic and regional effects of dopamine and dobutamine on patients with cardiomyopathic heart failure. Circulation 1978; 58: 466-75.
2. Van Trigt P, Spray TL, Pasque MK - The comparative effects of dopamine and dobutamine on ventricular mechanics after coronary artery bypass grafting: a pressure-dimensions analysis. Circulation 1984; 70(suppl): I-112-17.
3. Colucci SW, Richard FW, Jaski BE, Fifer MA, Braunwald E - Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness. Circulation 1986; 73: 175-83.
4. Grose R, Strain J, Greenberg M, Lejemtel TH - Systemic and coronary effects of intravenous milrinone and dobutamine on congestive heart failure. J Am Coll Cardiol 1986; 7: 1107-113.
5. Jaski BE, Fife MA, Wright RF, Braunwald E, Colucci WS - Positive inotropic and vasodilating actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprussiate. J Clin Invest 1985; 75: 643-59.
6. Bristow MR, Ginsburg R, Minobe W, et al - Decreased catecholamine sensitivity and β-adrenergic-receptor density in failing human hearts. N Engl J Med 1982; 307: 205-10.
7. Bristow MR - The adrenergic system in heart failure. N Engl J Med 1984; 311: 350-61.
8. Farah AE, Alonsi AA - New cardiotonic agents: a research for digital substitute. Life 1978; 22: 1139-41.
9. Joseph B, Grossman W, Braunwald E, Alonsi AA - Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med 1978; 299: 1373-7.
10. Earl CQ, Linden J, Weglicki WB - Biochemical mechanisms for the inotropic effect of the cardiotonic drug milrinone. J Cardiovasc Pharmacol 1986; 8: 864-72.
11. Bianco RD - Acute positive inotropic intervention: the phosphodiesterase inhibitors. Am Heart J 1991; 121: 1371-8.
12. Evans DB - Overview of cardiovascular physiology and pharmacologic aspects of selective phosphodiesterase peak III inhibitors. Am J Cardiol 1989; 63: 9A-11A.
13. Scholz H, Meyer W - Phosphodiesterase inhibiting properties of new inotropic agents. Circulation 1986; 73(suppl III): 99-108.
14. nd ed. New York: Raven Press, 1992: 83-8.
15. Matsubara BB, Bregagnollo EA, Ribeiro MACL, Tucci PJF - Relações pressão/diâmetro e esforço/diâmetro do ventrículo esquerdo em seres humanos. Padronização e análise crítica do método. Arq Bras Cardiol 1990; 54: 373-81.
16. Baim DS, McDowell AV, Chermilles J - Evaluation of a new bipiridine agent milrinone in patients with severe congestive heart failure. N Engl J Med 1983; 309: 748-56.
17. Maskin CS, Sinoway L, Chadwick B, Sonnenblick EH - Sustained hemodynamic and clinical effects of a new cardiotonic agent WIN 47203 on patients with severe congestive heart failure. Circulation 1983; 67: 1065-70.
18. Braunwald E, Covell JW - Evaluation of the efficacy of new inotropic agents. J Am Coll Cardiol 1984; 3: 1570-4.
19. Parmley WW - Pathophysiology and current therapy of congestive heart failure. J Am Coll Cardiol 1989; 13: 771-85.
20. Bristow MR, Hershberger RE, Port JD, et al - Beta-adrenergic pathways in non-failing and failing human ventricular myocardium. Circulation 1990; 82(suppl): 12-15.
21. Silver PJ, Lepore RE, O'Connor B - Inhibition of the low km cyclic AMP phosphodiesterase and activation of the cyclic system in vascular smooth muscle by milrinone. J Pharmacol Exp Ther 1988; 247: 34-42.
22. Gleason WL, Braunwald E - Studies on the first derivative of the ventricular pulse in man. J Clin Invest 1961; 41: 80-91.
23. Wallace AG, Skiner NS, Mitche JH - Hemodynamic determinants of the maximal rate of left ventricular pressure. Am J Physiol 1963; 205: 30-6.
24. Bregagnollo EA, Matsubara BB, Tucci PJF - Influência da elevação transitória e sustentada da pressão arterial sobre a primeira derivada temporal da pressão ventricular esquerda. Arq Bras Cardiol 1992; 58: 437-43.
25. Quinones MA, Gaash WH, Alexander JK - Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man. Circulation 1976; 52: 293-302.
26. Borow KM, Come PC, Neumann A, Baim DS, Braunwald E, Grossman W - Physiologic assessment of inotropic, vasodilating and afterload reducing effects of milrinone on subjects without cardiac disease. Am J Cardiol 1985; 55: 1204-9.
27. Sonnenblick EH, Grose R, Strain J, Zelcer AA, Lejemtel TH - Effects of milrinone on left ventricular performance and myocardial contractility in patients with severe heart failure. Circulation 1986; 73(suppl III): 162-7.
28. Monrad ES, Bain DS, Smith HS, Lanone B, Braunwald E, Grossman W -Effects of milrinone on coronary hemodynamics and myocardial energetics in patients with congestive heart failure. Circulation 1985; 71: 972-9.
29. Cody RJ, Muller FB, Kubo SH, Rutman H, Leonard D - Identification of the direct vasodilating effect of milrinone with chronic congestive heart failure. Circulation 1986; 73: 124-9.
30. Young RA, Ward A - Milrinone: a preliminary review of its pharmacological properties and therapeutical use. Drugs 1988; 36: 158-92.
31. Gun C, Piegas LS, Bianco ACM, Freire RBP, Ramos RF, Timerman A - Valor do uso da milrinona no tratamento das crises de agudização em portadores de insuficiência cardíaca congestiva. Arq Bras Cardiol 1995; 65: 255-8.
32. Bain DS - Effect of phosphodiesterase inhibition on myocardial oxygen consumption and coronary blood flow. Am J Cardiol 1989; 63: 23A-6A.
33. Monrad ES, Bain DS, Smith HS, Lanone AS - Milrinone, dobutamine and nitroprussiate: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure. Circulation 1986; 73(suppl III): 168-74.
34. Alonsi AA, Canter JM, Montenaro MJ, Fort DJ, Ferrari RA - Cardiotonic activity of milrinone: a new and potent cardiac bipiridine stimulant on the normal and failing heart of experimental animal. J Cardiovasc Pharmacol 1983; 5:792-803.
35. Alonsi AA, Stankus GP, Stuart JC, Walton LH - Characterization of the cardiotonic effect of milrinone on isolated tissues from several animal species. J Cardiovasc Pharmacol 1983; 5: 804-11.